Biopharma Stocks Show Resilience In Yo-Yo Week

Traders “whipsawed” biotech stocks but still the IBB managed to hold onto short-term gains of 10 points over the intermediate support of $280.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.